Foch Hospital is a celebrated teaching hospital in the Suresnes, France. Part of the Établissement de santé privé d'intérêt collectif and a teaching hospital of Versailles Saint-Quentin-en-Yvelines University, it is one of Europe's largest hospitals.

There are 600 beds in Hôpital Foch.

During the past decade, Hôpital Foch conducted 250 clinical trials. In the 10-year time frame, 250 clinical trials started and 22 clinical trials were completed, i.e. on average, 8.8% percent of trials that started reached the finish line to date. In the past 5 years, 119 clinical trials started and 14 clinical trials were completed. i.e. 11.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Foch" #1 sponsor was "Hopital Foch" with 162 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 20 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 15 trials sponsored, "Nantes University Hospital" with 14 trials sponsored and "UNICANCER" with 14 trials sponsored. Other sponsors include 174 different institutions and companies that sponsored additional 95 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Foch" #1 collaborator was "Ministry of Health, France" with 7 trials as a collaborator, "Astellas Pharma Inc" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "National Cancer Institute, France" with 4 trials as a collaborator and "Roche Pharma AG" with 4 trials as a collaborator. Other collaborators include 127 different institutions and companies that were collaborators in the rest 116 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Foch" are "Anesthesia" (23 trials), "Cystic Fibrosis" (13 trials), "Prostate Cancer" (11 trials), "Bladder Cancer" (9 trials) and "Pain" (9 trials). Many other conditions were trialed in "Hôpital Foch" in a lesser frequency.

Most popular intervention types in "Hôpital Foch" are "Drug" (164 trials), "Other" (82 trials), "Device" (77 trials), "Procedure" (48 trials) and "Biological" (33 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "radiation therapy" (9 trials), "fluorouracil" (8 trials), "Gemcitabine" (7 trials) and "Nivolumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Foch" are 326 trials for "All" genders, 39 trials for "Female" genders and 37 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Foch". 3 are not yet recruiting, 84 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 210 completed trials in Hôpital Foch, undefined suspended trials, and 47 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Foch, 3 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 150 trials that are defined as “Not Applicable".

Hôpital Foch has several departments that took part in Clinical trials: "Hopital Foch; Oncologie" - 6 trials, "Dept of Anesthesia, Hôpital Foch" - 5 trials, "Hopital Foch; Pneumologie" - 4 trials, "Dept of Anesthesiology, Hôpital Foch" - 3 trials, "Department of Transplantation, Nephrology and Clinical Immunology, Hôpital Foch" - 2 trials, "Hopital Foch; Neurologie" - 2 trials, "Service d'Urologie, Hôpital Foch" - 2 trials